Answer
Binimetinib in combination with encorafenib is indicated for adults with advanced non-small cell lung cancer with a BRAF V600E mutation.
Sources for this answer
- Mektovi 15 mg film-coated tabletsPierre Fabre Limited · emc · SmPC §4.1 Therapeutic Indications · Version 9Document updated
Sources checked